<DOC>
	<DOC>NCT00406042</DOC>
	<brief_summary>To evaluate whether or not using topical steroids after selective laser trabeculoplasty affects intraocular pressure outcomes.</brief_summary>
	<brief_title>The Role of Steroids Following Selective Laser Trabeculoplasty</brief_title>
	<detailed_description>Subjects undergoing bilateral SLT will be randomly assigned to use prednisolone acetate 1% in one eye four times daily with no treatment in the fellow eye, for one week following SLT. Examinations will occur at baseline, and one week, one month and three months after SLT. IOP and anterior chamber inflammation will be noted at each visit.</detailed_description>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>glaucoma or ocular hypertension need for bilateral SLT eye disease precluding accurate IOP measurement contraindication to topical prednisolone acetate</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2007</verification_date>
	<keyword>glaucoma</keyword>
	<keyword>trabeculoplasty</keyword>
	<keyword>steroids</keyword>
</DOC>